Grifols (GIFLF) Dividends Paid - Common (2015 - 2019)
Grifols (GIFLF) reported Dividends Paid - Common of -$108.9 million for Q4 2019, down 168.65% on a YoY basis from $158.7 million in Q4 2018, and down 168.65% quarter-over-quarter from $158.7 million in Q4 2018.
Grifols (GIFLF) Dividends Paid - Common (2015 - 2019) Analysis & Trends
Grifols has reported Dividends Paid - Common for 5 years, with the latest figure at -$108.9 million in Q4 2019.
- For the quarter ending Q4 2019, Dividends Paid - Common fell 168.65% year-over-year to -$108.9 million; the trailing twelve-month figure through Dec 2019 stood at $496.0 million (up 25.0% YoY), and the FY2025 full-year result was $149.0 million, up 13843.31% from the prior year.
- Dividends Paid - Common for Q4 2019 stood at -$108.9 million, down from $158.7 million in the prior quarter.
- The five-year high for Dividends Paid - Common was $334.1 million in Q4 2016, with the low at -$208.2 million in Q3 2016.
- Historically, Dividends Paid - Common has averaged $69.8 million across 5 years, with a median of $121.6 million in 2015.
- Annual changes were most pronounced in 2016 — Dividends Paid - Common surged 154.79% — and 2019, when it plunged 168.65%.
- Grifols' Dividends Paid - Common stood at $131.1 million in 2015, then surged by 154.79% to $334.1 million in 2016, then tumbled by 66.42% to $112.2 million in 2017, then soared by 41.47% to $158.7 million in 2018, then sank by 168.65% to -$108.9 million in 2019.
- The last three Dividends Paid - Common figures came in at -$108.9 million (Q4 2019), $158.7 million (Q4 2018), and $112.2 million (Q4 2017), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 96,436,181.12 Bn | 96,436,176.16 Bn | 7.76 Bn | -866.88 Mn |
| 2 | Eli Lilly | 1,017.30 Bn | 1,012.01 Bn | 16.22 Bn | 1.55 Bn |
| 3 | Johnson & Johnson | 579.61 Bn | 557.55 Bn | 15.96 Bn | 3.13 Bn |
| 4 | AbbVie | 402.30 Bn | 392.96 Bn | 10.78 Bn | 3.09 Bn |
| 5 | Merck | 294.24 Bn | 288.59 Bn | 12.09 Bn | 2.11 Bn |
| 6 | Amgen | 191.82 Bn | 179.78 Bn | 5.87 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | 1.04 Bn |
| 8 | Pfizer | 149.05 Bn | 136.28 Bn | -1.21 Bn | 2.45 Bn |
| 9 | Bristol Myers Squibb | 116.33 Bn | 105.88 Bn | 8.07 Bn | 1.28 Bn |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -108.94 Mn |
| Dec 31, 2019 | -108.94 Mn |
| Dec 31, 2018 | 158.70 Mn |
| Dec 31, 2018 | 158.70 Mn |
| Dec 31, 2017 | 112.18 Mn |
| Dec 31, 2017 | 112.18 Mn |
| Dec 31, 2016 | 334.06 Mn |
| Dec 31, 2016 | 334.06 Mn |
| Sep 30, 2016 | -208.15 Mn |
| Sep 30, 2016 | -208.15 Mn |
| Dec 31, 2015 | 131.11 Mn |
| Dec 31, 2015 | 131.11 Mn |